Posted May 08, 2018 03:16:48In a small trial published on Thursday, researchers in the United Kingdom reported that the first vaccine for vaccinating against the coronavirus (COVID-19) is now effective in a small population of people.
A team of researchers at King’s College London (KCL) reported that vaccinated people are able to avoid the onset of coronaviruses with low doses of the coronovirus vaccine.
The team followed 1,100 people who had been vaccinated at KCL’s Vaccine and Research Centre between January and March of 2019, and followed up with 2,400 participants who had not received the vaccine.
They found that people who received the first dose of the vaccine were 99.6 per cent less likely to contract COVID-20 by 2019, compared with people who did not receive the vaccine and who had received the second dose of vaccine.
Those who had the second vaccine, the team reported, were 98.9 per cent more likely to recover from the disease.
The researchers concluded that the vaccine is “effective in the treatment of COVID” and is a “highly promising approach” to vaccinating people who have not yet been vaccinated.
“We now know that there is an advantage to vaccination that is potentially very important in the long term,” said Dr. Peter Wilson, the study’s senior author and head of the Vaccine Research Centre.
“People who have been vaccinated before this will continue to benefit from the vaccine even if they have not received any of the subsequent doses of vaccine, and this may be a critical factor in its success in the short term.”
The researchers noted that there was also an increased risk of COV-19 transmission among vaccinated people, and that this risk is lower in the longer term than it is in the study population.
There is still much work to be done in the vaccine, they said.
They did not report the outcome of the study.